Translocator protein (TSPO) affects mitochondrial fatty acid oxidation in steroidogenic cells

Endocrinology

Volumn 157, Issue 3, 2016, Pages 1110-1121

  Tu, Lan N ^a   Zhao, Amy H ^a   Hussein, Mahmoud ^a   Stocco, Douglas M ^b   Selvaraj, Vimal ^a  

^a Plant Breeding and Genetics Section in the School of Integrative Plant Science   (United States)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; FATTY ACID; GLUCOSE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; TRANSLOCATOR PROTEIN; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 2; 4 AMINOBUTYRIC ACID RECEPTOR; BZRP PROTEIN, MOUSE; ION CHANNEL; ISOCITRATE DEHYDROGENASE; ISOCITRATE DEHYDROGENASE 2, MOUSE; MESSENGER RNA; MITOCHONDRIAL PROTEIN; PROGESTERONE; VDAC1 PROTEIN, MOUSE; VOLTAGE DEPENDENT ANION CHANNEL 1;

ADRENAL GLAND; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOENERGY; CELL CLONE; CONTROLLED STUDY; CRISPR CAS SYSTEM; ENERGY YIELD; FATTY ACID OXIDATION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE INACTIVATION; GENE OVEREXPRESSION; LEYDIG CELL; LIPID METABOLISM; LIPID STORAGE; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL RESPIRATION; MOUSE; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTON TRANSPORT; STEROID RELEASE; UPREGULATION; WESTERN BLOTTING; ANIMAL; GENETICS; KNOCKOUT MOUSE; METABOLISM; MITOCHONDRION; OXIDATION REDUCTION REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; FATTY ACIDS; GENE EXPRESSION REGULATION; ION CHANNELS; ISOCITRATE DEHYDROGENASE; LEYDIG CELLS; LIPID METABOLISM; MALE; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MICE, KNOCKOUT; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; OXIDATION-REDUCTION; PROGESTERONE; REACTIVE OXYGEN SPECIES; RECEPTORS, GABA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UNCOUPLING PROTEIN 2; VOLTAGE-DEPENDENT ANION CHANNEL 1;

EID: 84960532896     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2015-1795     Document Type: Article

References (72)

1. Braestrup C, Squires RF. Specific benzodiazepine receptors in rat brain characterized by high-affinity (3H) diazepam binding. Proc Natl Acad Sci USA. 1977;74:3805-3809.
2. Yeliseev AA, Kaplan S. A sensory transducer homologous to the mammalian peripheral-type benzodiazepine receptor regulates photosynthetic membrane complex formation in Rhodobacter sphaeroides 2.4.1. J Biol Chem. 1995;270:21167-21175.
3. Gavish M, Bachman I, Shoukrun R, et al. Enigma of the peripheral benzodiazepine receptor. Pharmacol Rev. 1999;51:629-650.
4. Gatliff J, Campanella M. The 18 kDa translocator protein (TSPO): a new perspective in mitochondrial biology. Curr Mol Med. 2012;12:356-368.
5. Papadopoulos V, Amri H, Boujrad N, et al. Peripheral benzodiazepine receptorincholesterol transport and steroidogenesis. Steroids. 1997;62:21-28.
6. Papadopoulos V, Miller WL. Role of mitochondria in steroidogenesis. Best Pract Res Clin Endocrinol Metab. 2012;26:771-790.
7. Anholt RR, Pedersen PL, De Souza EB, Snyder SH. The peripheraltype benzodiazepine receptor. Localization to the mitochondrial outer membrane. J Biol Chem. 1986;261:576-583.
8. Morohaku K, Pelton SH, Daugherty DJ, Butler WR, Deng W, Selvaraj V. Translocator protein/peripheral benzodiazepine receptor is not required for steroid hormone biosynthesis. Endocrinology. 2014;155:89-97.
9. Tu LN, Morohaku K, Manna PR, et al. Peripheral benzodiazepine receptor/translocator protein global knock-out mice are viable with no effects on steroid hormone biosynthesis. J Biol Chem. 2014;289:27444-27454.
10. Banati RB, Middleton RJ, Chan R, et al. Positron emission tomography and functional characterization of a complete PBR/TSPO knockout. Nat Commun. 2014;5:5452.
11. Tu LN, Zhao AH, Stocco DM, Selvaraj V. PK11195 effect on steroidogenesis is not mediated through the translocator protein (TSPO). Endocrinology. 2015:156:1033-1039.
12. Selvaraj V, Stocco DM, Tu LN. Minireview: translocator protein (TSPO) and steroidogenesis: a reappraisal. Mol Endocrinol. 2015;29:490-501.
13. Selvaraj V, Stocco DM. The changing landscape in translocator protein (TSPO) function. Trends EndocrinolMetab. 2015;26:341-348.
14. Fan J, Campioli E, Midzak A, Culty M, Papadopoulos V. Conditional steroidogenic cell-targeted deletion of TSPO unveils a crucial role in viability and hormone-dependent steroid formation. Proc Natl Acad Sci USA. 2015;112:7261-7266.
15. De Souza EB, Anholt RR, Murphy KM, Snyder SH, Kuhar MJ. Peripheral-type benzodiazepine receptors in endocrine organs: autoradiographic localization in rat pituitary, adrenal, and testis. Endocrinology. 1985;116:567-573.
16. Bribes E, Carrière D, Goubet C, Galiègue S, Casellas P, Simony-Lafontaine J. Immunohistochemical assessment of the peripheral benzodiazepine receptor in human tissues. J Histochem Cytochem. 2004;52:19-28.
17. Morohaku K, Phuong NS, Selvaraj V. Developmental expression of translocator protein/peripheral benzodiazepine receptor in reproductive tissues. PLoS One. 2013;8:e74509.
18. Larcher JC, Vayssiere JL, Le Marquer FJ, et al. Effects of peripheral benzodiazepines upon the O2 consumption of neuroblastoma cells. Eur J Pharmacol. 1989;161:197-202.
19. Hirsch JD, Beyer CF, Malkowitz L, Beer B, Blume AJ. Mitochondrial benzodiazepine receptors mediate inhibition of mitochondrial respiratory control. Mol Pharmacol. 1989;35:157-163.
20. Maaser K, Sutter AP, Scherübl H. Mechanisms of mitochondrial apoptosis induced by peripheral benzodiazepine receptor ligands in human colorectal cancer cells. Biochem Biophys Res Commun. 2005;332:646-652.
21. Furre IE, Shahzidi S, Luksiene Z, et al. Targeting PBR by hexaminolevulinate-mediated photodynamic therapy induces apoptosis through translocation of apoptosis-inducing factor in human leukemia cells. Cancer Res. 2005;65:11051-11060.
22. Hong SH, Choi HB, Kim SU, McLarnon JG. Mitochondrial ligand inhibits store-operated calcium influx and COX-2 production in human microglia. J Neurosci Res. 2006;83:1293-1298.
23. Campanella M, Szabadkai G, Rizzuto R. Modulation of intracellular Ca2+ signalling in HeLa cells by the apoptotic cell death enhancer PK11195. Biochem Pharmacol. 2008;76:1628-1636.
24. Fennell DA, Corbo M, Pallaska A, Cotter FE. Bcl-2 resistant mitochondrial toxicity mediated by the isoquinoline carboxamide PK11195 involves de novo generation of reactive oxygen species. Br J Cancer. 2001;84:1397-1404.
25. Zeno S, Veenman L, Katz Y, Bode J, Gavish M, Zaaroor M. The 18 kDa mitochondrial translocator protein (TSPO) prevents accumulation of protoporphyrin IX. Involvement of reactive oxygen species (ROS). Curr Mol Med. 2012;12:494-501.
26. Scarf AM, Auman KM, Kassiou M. Is there any correlation between binding and functional effects at the translocator protein (TSPO) (18 kDa) ? Curr Mol Med. 2012;12:387-397.
27. Li L, Chen T, Stanton JD, Sueyoshi T, Negishi M, Wang H. The peripheral benzodiazepine receptor ligand 1-(2-chlorophenyl-methylpropyl)-3-isoquinoline-carboxamide is a novel antagonist of human constitutive androstane receptor. Mol Pharmacol. 2008;74:443-453.
28. Seneviratne MS, Faccenda D, De Biase V, Campanella M. PK11195 inhibits mitophagy targeting the F1Fo-ATPsynthase in Bcl-2 knockdown cells. Curr Mol Med. 2012;12:476-482.
29. Hatty CR, Le Brun AP, Lake V, et al. Investigating the interactions of the 18kDa translocator protein and its ligand PK11195 in planar lipid bilayers. Biochim Biophys Acta. 2014;1838:1019-1030.
30. Kinnally KW, Zorov DB, Antonenko YN, Snyder SH, McEnery MW, Tedeschi H. Mitochondrial benzodiazepine receptor linked to inner membrane ion channels by nanomolar actions of ligands. Proc Natl Acad Sci USA. 1993;90:1374-1378.
31. Šileikyt J, Blachly-Dyson E, Sewell R, et al. Regulation of the mitochondrial permeability transition pore by the outer membrane does not involve the peripheral benzodiazepine receptor (translocator protein of 18 kDa (TSPO)). J Biol Chem. 2014;289:13769-13781.
32. Mukhin AG, Papadopoulos V, Costa E, Krueger KE. Mitochondrial benzodiazepine receptors regulate steroid biosynthesis. Proc Natl Acad Sci USA. 1989;86:9813-9816.
33. Ascoli M. Characterization of several clonal lines of cultured Leydig tumor cells: gonadotropin receptors and steroidogenic responses. Endocrinology. 1981;108:88-95.
34. Campeau E, Ruhl VE, Rodier F, et al. A versatile viral system for expression and depletion of proteins in mammalian cells. PLoS One. 2009;4:e6529.
35. Spandidos A, Wang X, Wang H, Seed B. PrimerBank: a resource of human and mouse PCR primer pairs for gene expression detection and quantification. Nucleic Acids Res. 2010;38:D792-D799.
36. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-ΔΔC (T)) method. Methods. 2001;25:402-408.
37. Anholt RR, De Souza EB, Oster-Granite ML, Snyder SH. Peripheraltype benzodiazepine receptors: autoradiographic localization in whole-body sections of neonatal rats. J Pharmacol Exp Ther. 1985;233:517-526.
38. Leduc MS, Hageman RS, Verdugo RA, et al. Integration of QTL and bioinformatic tools to identify candidate genes for triglycerides in mice. J Lipid Res. 2011;52:1672-1682.
39. Wade FM, Wakade C, Mahesh VB, Brann DW. Differential expression of the peripheral benzodiazepine receptor and gremlin during adipogenesis. Obes Res. 2005;13:818-822.
40. Lee DH, Kang SK, Lee RH, et al. Effects of peripheral benzodiazepine receptor ligands on proliferation and differentiation of human mesenchymal stem cells. J Cell Physiol. 2004;198:91-99.
41. Thompson MM, Manning HC, Ellacott KL. Translocator protein 18 kDa (TSPO) is regulated in white and brown adipose tissue by obesity. PLoS One. 2013;8:e79980.
42. Dimitrova-Shumkovska J, Veenman L, Ristoski T, Leschiner S, Gavish M. Chronic high fat, high cholesterol supplementation decreases 18 kDa Translocator Protein binding capacity in association with increased oxidative stress in rat liver and aorta. Food Chem Toxicol. 2010;48:910-921.
43. Buettner R, Parhofer KG, Woenckhaus M, et al. Defining high-fatdiet rat models: metabolic and molecular effects of different fat types. J Mol Endocrinol. 2006;36:485-501.
44. Fritz IB, Yue KT. Long-chain carnitine acyltransferase and the role of acylcarnitine derivatives in the catalytic increase of fatty acid oxidation induced by carnitine. J Lipid Res. 1963;4:279-288.
45. Vats D, Mukundan L, Odegaard JI, et al. Oxidative metabolism and PGC-1β attenuate macrophage-mediated inflammation. Cell Metab. 2006;4:13-24.
46. Shriver LP, Manchester M. Inhibition of fatty acid metabolism ameliorates disease activity in an animal model of multiple sclerosis. Sci Rep. 2011;1:79.
47. Samudio I, Harmancey R, Fiegl M, et al. Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction. J Clin Invest. 2010;120:142-156.
48. Pike LS, Smift AL, Croteau NJ, Ferrick DA, Wu M. Inhibition of fatty acid oxidation by etomoxir impairs NADPH production and increases reactive oxygen species resulting in ATP depletion and cell death in human glioblastoma cells. Biochim Biophys Acta. 2011;1807:726-734.
49. Carracedo A, Cantley LC, Pandolfi PP. Cancer metabolism: fatty acid oxidation in the limelight. Nat Rev Cancer. 2013;13:227-232.
50. Zhao AH, Tu LN, Mukai C, et al. Mitochondrial translocator protein (TSPO) function is not essential for heme biosynthesis. J Biol Chem. doi: 10.1074/jbc. M115.686360.
51. Carayon P, Portier M, Dussossoy D, et al. Involvement of peripheral benzodiazepine receptors in the protection of hematopoietic cells against oxygen radical damage. Blood. 1996;87:3170-3178.
52. de Tassigny Ad, Assaly R, Schaller S, Pruss RM, Berdeaux A, Morin D. Mitochondrial translocator protein (TSPO) ligands prevent doxorubicin-induced mechanical dysfunction and cell death in isolated cardiomyocytes. Mitochondrion. 2013;13:688-697.
53. Veenman L, Shandalov Y, Gavish M. VDAC activation by the 18 kDa translocator protein (TSPO), implications for apoptosis. JBioenerg Biomembr. 2008;40:199-205.
54. Gatliff J, East D, Crosby J, et al. TSPO interacts with VDAC1 and triggers a ROS-mediated inhibition of mitochondrial quality control. Autophagy. 2014;10:2279-2296.
55. Klubo-Gwiezdzinska J, Jensen K, Bauer A, et al. The expression of translocator protein in human thyroid cancer and its role in the response of thyroid cancer cells to oxidative stress. J Endocrinol. 2012;214:207-216.
56. Rosca MG, Vazquez EJ, Chen Q, Kerner J, Kern TS, Hoppel CL. Oxidation of fatty acids is the source of increased mitochondrial reactive oxygen species production in kidney cortical tubules in early diabetes. Diabetes. 2012;61:2074-2083.
57. Schönfeld P, Wojtczak L. Brown adipose tissue mitochondria oxidizing fatty acids generate high levels of reactive oxygen species irrespective of the uncoupling protein-1 activity state. Biochim Biophys Acta. 2012;1817:410-418.
58. Andrews ZB, Liu ZW, Walllingford N, et al. UCP2 mediates ghrelin's action on NPY/AgRP neurons by lowering free radicals. Nature. 2008;454:846-851.
59. Pi J, Collins S. Reactive oxygen species and uncoupling protein 2 in pancreatic β-cell function. Diabetes Obes Metab. 2010;12(suppl 2):141-148.
60. Vozza A, Parisi G, De Leonardis F, et al. UCP2 transports C4 metabolites out of mitochondria, regulating glucose and glutamine oxidation. Proc Natl Acad Sci USA. 2014;111:960-965.
61. Kukat A, Dogan SA, Edgar D, et al. Loss of UCP2 attenuates mitochondrial dysfunction without altering ROS production and uncoupling activity. PLoS Genet. 2014;10:e1004385.
62. Burton M, Rose TM, Faergeman NJ, Knudsen J. Evolution of the acyl-CoA binding protein (ACBP). BiochemJ. 2005;392:299-307.
63. Bovolin P, Schlichting J, Miyata M, Ferrarese C, Guidotti A, Alho H. Distribution and characterization of diazepam binding inhibitor (DBI) in peripheral tissues of rat. Regul Pept. 1990;29:267-281.
64. Papadopoulos V, Berkovich A, Krueger KE, Costa E, Guidotti A. Diazepam binding inhibitor and its processing products stimulate mitochondrial steroid biosynthesis via an interaction with mitochondrial benzodiazepine receptors. Endocrinology. 1991;129:1481-1488.
65. Neess D, Bloksgaard M, Bek S, et al. Disruption of the acyl-CoA-binding protein gene delays hepatic adaptation to metabolic changes at weaning. J Biol Chem. 2011;286:3460-3472.
66. Lee L, De Bono CA, Campagna DR, Young DC, Moody DB, Fleming MD. Loss of the acyl-CoA binding protein (Acbp) results in fatty acid metabolism abnormalities in mouse hair and skin. J Invest Dermatol. 2007;127:16-23.
67. Toranzo D, Tong Y, Tonon MC, Vaudry H, Pelletier G. Localization of diazepam-binding inhibitor and peripheral type benzodiazepine binding sites in the rat ovary. Anat Embryol (Berl). 1994;190:383-388.
68. Tong Y, Rhéaume E, Simard J, Pelletier G. Localization of peripheral benzodiazepine binding sites and diazepam-binding inhibitor (DBI) mRNA in mammary glands and dimethylbenz (a) antracene (DMBA)-induced mammary tumors in the rat. Regul Pept. 1991;33:263-273.
69. Mandrup S, Sorensen RV, Helledie T, et al. Inhibition of 3T3-L1 adipocyte differentiationbyexpressionofacyl-CoA-binding protein antisense RNA. J Biol Chem. 1998;273:23897-23903.
70. McEnery MW, Snowman AM, Trifiletti RR, Snyder SH. Isolation of the mitochondrial benzodiazepine receptor: association with the voltage-dependent anion channel and theadenine nucleotide carrier. Proc Natl Acad Sci USA. 1992;89:3170-3174.
71. Lee K, Kerner J, Hoppel CL. Mitochondrial carnitine palmitoyltransferase 1a (CPT1a) is part of an outer membrane fatty acid transfer complex. J Biol Chem. 2011;286:25655-25662.
72. Rao JN, Warren GZ, Estolt-Povedano S, Zammit VA, Ulmer TS. An environment-dependent structural switch underlies the regulation of carnitine palmitoyltransferase 1A. J Biol Chem. 2011;286:42545-42554.